Owners, management and financials
CVR: 38729888
Secondary names: PFS Components A/S, First Parenteral Packaging A/S, Lubrigone A/S
Previous names: Lubrigone A/S
DKK -2,590,948
Gross profit
Net result: DKK -2,942,694
Injecto Group A/S (100%)
CVR · view owners
Torben Helmer Knudsen
Board: John Holger Adamsen (chair) and 2 members
CVR · view management
Active
Founded 19 June 2017
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: Injecto A/S
CVR · 23/11/2019
View the full event history
Injecto A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Lubrigone A/S. The management consists of Torben Helmer Knudsen. The board consists of John Holger Adamsen (chair), Carsten Sylvester Larsen and Torben Helmer Knudsen. The company is owned by Injecto Group A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,590,948 and a net result of DKK -2,942,694 compared with DKK -2,982,525 the year before. Equity in the 2025 report amounted to DKK -43,454.
Virksomhedens formål er at drive virksomhed med udvikling, produktion, markedsføring og distribution af komponenter til farmaceutisk indpakning med hovedvægt på præfyldte sprøjter og dermed efter bestyrelsens opfattelse beslægtet virksomhed, herunder eje kapitalandele i associerede selskaber.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/09/2024 – 31/08/2025 | -2.6 mio. | -2.9 mio. | 3 mio. | -43 t. | 0 | |
| 202401/09/2023 – 31/08/2024 | -2.9 mio. | -3 mio. | 2.8 mio. | 399 t. | - | |
| 202301/09/2022 – 31/08/2023 | -1.6 mio. | -2.6 mio. | 4 mio. | 3.4 mio. | - | |
| 202201/09/2021 – 31/08/2022 | -2.9 mio. | -4.1 mio. | 2.4 mio. | -7 mio. | - | |
| 202101/09/2020 – 31/08/2021 | -2 mio. | -2.5 mio. | 2.2 mio. | -2.9 mio. | - | |
| 202001/09/2019 – 31/08/2020 | -2.5 mio. | -2.5 mio. | 2.8 mio. | -360 t. | - | |
| 201901/09/2018 – 31/08/2019 | -19 t. | -31 t. | 3 mio. | 2.1 mio. | - |
Compared to 307 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Injecto A/S is 38729888.
Injecto A/S is owned by Injecto Group A/S.
The management of Injecto A/S consists of Torben Helmer Knudsen.
The board of Injecto A/S consists of John Holger Adamsen, Carsten Sylvester Larsen and Torben Helmer Knudsen, with John Holger Adamsen as chair.
In 2025, Injecto A/S reported a gross profit of DKK -2,590,948.
Injecto A/S had an average of 0 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Injecto A/S has published its annual report for 2025. Gross profit came to DKK -2,590,948, and the net result was DKK -2,942,694.
Injecto A/S has published its annual report for 2024. Gross profit came to DKK -2,866,909, and the net result was DKK -2,982,525.
As of August 21, 2024, Carsten Sylvester Larsen has joined the board of directors of Injecto A/S.
As of August 21, 2024, Thomas Sonne-Schmidt has left the board of directors of Injecto A/S.
Injecto A/S has published its annual report for 2023. Gross profit came to DKK -1,585,250, and the net result was DKK -2,626,586.
As of August 28, 2023, John Holger Adamsen has joined the board of directors of Injecto A/S.
As of August 28, 2023, Thomas Sonne-Schmidt has joined the board of directors of Injecto A/S.
As of August 28, 2023, Mikael Hans Andranik Hetting has left the board of directors of Injecto A/S.
As of August 27, 2023, John Holger Adamsen has left the board of directors of Injecto A/S.
Injecto A/S has published its annual report for 2022. Gross profit came to DKK -2,931,492, and the net result was DKK -4,086,418.
Injecto A/S has published its annual report for 2021. Gross profit came to DKK -1,984,229, and the net result was DKK -2,544,782.
Injecto A/S has published its annual report for 2020. Gross profit came to DKK -2,457,897, and the net result was DKK -2,508,667.
Injecto A/S has published its annual report for 2019. Gross profit came to DKK -18,580, and the net result was DKK -30,802.
On November 23, 2019, the company changed its name from Lubrigone A/S to Injecto A/S.
Injecto A/S has published its interim report for the period June 19, 2017 to August 31, 2018.
As of June 19, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Injecto A/S.
As of June 19, 2017, John Holger Adamsen has joined the board of directors of Injecto A/S.
As of June 19, 2017, Mikael Hans Andranik Hetting has joined the board of directors of Injecto A/S.
As of June 19, 2017, Torben Helmer Knudsen has joined the board of directors of Injecto A/S.
As of June 19, 2017, Torben Helmer Knudsen is registered as adm. dir. of Injecto A/S.
As of June 19, 2017, Injecto Group A/S is registered as an owner of Injecto A/S with an ownership share of 100%.
Injecto A/S was founded on June 19, 2017.
Companies in the same industry and area
CVR 35806555
CVR 36949740
CVR 38401572
CVR 55730156
CVR 38818791
